GE Healthcare to organize ‘GE MR Academy’ that suggests the roadmap for the MR contrast media products development

GE Healthcare to organize ‘GE MR Academy’ that suggests the roadmap for the MR contrast media products development

 Academy to share the MR study trend inviting radiologists from the Korean Society of Magnetic Resonance in Medicine 
 Shared the latest knowledge, safety, and its future roadmap for MR imaging agent ClariscanTM 
 Presented the status of AI technology study in the radiology and its clinical study result 

(October 29, 2019) – GE Healthcare Korea and Korean Society of Magnetic Resonance in Medicine (Chairman Yeon Hyeon Choe (Director of the Imaging Department of Samsung Medical Center) today announced that, on October 25, held ‘GE MR Academy’ introducing research status through GE Healthcare’s MR imaging contrast ClariscanTM and AI in MR imaging, inviting radiologists in Korea.

Dr. Jean Pierre Pruvo, the professor of the Department of Neuroradiology at the Lille University Hospital in France introduced the experience of using MR imaging contrast Clariscan, launched last year in Korea, in Europe and its safety. Francois Roche global head of GE Healthcare Contrast Media Business introduced GE Healthcare’s R&D efforts and investment in the contrast media products realizing the company’s vision of precision health.

During the second session on the MR Imaging using AI, Dr. Ho Sung Kim of the Department of Radiology at Asan Medical Center, Seoul presented about his research and the clinical study in deep learning in the neuroradiology.

Yeon Hyeon Choe, Chairman of the Korean Society of Magnetic Resonance in Medicine said, “MR technology continues to evolve as its value for the sustainable medical service and workflow enhancement is highlighted. With collaborating with GE Healthcare, we hope to firm the partnership to advance the magnetic resonance in medicine via MR Academy.”

Francois Roche, Global head of GE Healthcare Contrast Media Business said, “Korea’s MR medical imaging capability is already highly regarded in the global market. We are proud to support medical researchers and professionals with GE contrast agent products. With Clariscan, GE is committed to invest more and support the medical professionals with accurate and reliable MR images.”

Launched last year in Korea, Clariscan is a gadolinium-based MRI contrast agent that is designed to visualize the abnormalities in the brain, spine, and associated tissues. Since its global launch in 2017, it is used in more than 3 million procedures.

# # #

About GE Healthcare:
GE Healthcare is the $19 billion healthcare business of GE (NYSE: GE). As a leading provider of medical imaging, monitoring, biomanufacturing, and cell and gene therapy technologies, GE Healthcare enables precision health in diagnostics, therapeutics and monitoring through intelligent devices, data analytics, applications and services. With over 100 years of experience in the healthcare industry and more than 50,000 employees globally, the company helps improve outcomes more efficiently for patients, healthcare providers, researchers and life sciences companies around the world. Follow us on Facebook, LinkedIn, Twitter and The Pulse for latest news, or visit our website www.gehealthcare.com for more information.